Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Uncover the best no annual fee rewards card for your needs. Our guide helps you navigate options to enhance your spending benefits.
23,056 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
DoorDash, Figma, and eBay report after market close, sending shares higher in extended trading. This live blog tracks...
LoanDepot moved to dismiss a West Capital Lending lawsuit in a California federal court, arguing the case lacks stand...
Pred secures a $2.5 million funding round led by ACCEL, aiming to deliver the fastest on-chain sports prediction trad...
Rocket Lab shares hover near $67 as July odds tilt toward downside. This story breaks down what prediction markets be...
NVIDIA stock has surprised some by not rallying in 2026 despite booming AI demand. This article breaks down why the s...
A private mint unveiled a $1 Trump commemorative coin to mark the United States' 250th birthday, sparking debate amon...
January data show a pending home sales fall, signaling continued headwinds for buyers even as rates move modestly low...
Global container rates surge again amid geopolitical tension and tariff uncertainty, reviving concerns about another ...
Investors have watched Comfort Systems soar in recent years. This guide evaluates whether should comfort systems stoc...
Berkshire Hathaway's big Alphabet stake marks a rare foray into technology by Warren Buffett. This article breaks dow...
A fresh institutional stake has emerged in Victoria’s Secret stock this quarter. The $8.5 million bet suggests some m...